Titlebook: Diagnosis and Treatment of Chronic Cough; Sang Heon Cho,Woo-Jung Song Book 2021 Springer Nature Singapore Pte Ltd. 2021 acute and chronic

IU421

書目名稱Diagnosis and Treatment of Chronic Cough影響因子(影響力)




書目名稱Diagnosis and Treatment of Chronic Cough影響因子(影響力)學(xué)科排名




書目名稱Diagnosis and Treatment of Chronic Cough網(wǎng)絡(luò)公開度




書目名稱Diagnosis and Treatment of Chronic Cough網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Diagnosis and Treatment of Chronic Cough被引頻次




書目名稱Diagnosis and Treatment of Chronic Cough被引頻次學(xué)科排名




書目名稱Diagnosis and Treatment of Chronic Cough年度引用




書目名稱Diagnosis and Treatment of Chronic Cough年度引用學(xué)科排名




書目名稱Diagnosis and Treatment of Chronic Cough讀者反饋




書目名稱Diagnosis and Treatment of Chronic Cough讀者反饋學(xué)科排名

carotid-bruit

Upper Airways: Assessment and Treatment for Cough,h cough are controversial. Despite their frequent overlaps, evidence is largely lacking on how to assess and treat upper airway conditions in patients with chronic cough. This chapter summarizes clinical evidence on upper airways and cough, but also introduces a pragmatic clinical approach based on the evidence and the authors’ clinical experience.

enlist

Interdict

Diagnostic and Therapeutic Trials for Chronic Cough in Adults: An Overview, tract, and the central nervous system. The choice of medication should be ideally based on clinical findings. However, in patients without apparent treatable traits, sequential empirical trials are considered, but physicians should evaluate positive and negative effects of such treatments and decid

Intentional

Pharmacological Management of Cough,parate disease characterised by hypersensitivity of the afferent vagus that investment in high-quality studies has been made. The finding that antagonism of the purinergic receptor P2X3 reduced cough counts has established chronic cough as a therapeutic opportunity. Gefapixant, the first in class P2

Firefly

https://doi.org/10.1007/978-3-319-65485-0rlying diseases. This understanding of “chronic cough driven by hypersensitivity” was named “cough hypersensitivity syndrome.” A greater understanding of the neuroinflammatory mechanisms in the peripheral and central nervous systems in chronic cough hypersensitivity will suggest more efficacious tar

Firefly

https://doi.org/10.1007/978-3-319-65485-0 tract, and the central nervous system. The choice of medication should be ideally based on clinical findings. However, in patients without apparent treatable traits, sequential empirical trials are considered, but physicians should evaluate positive and negative effects of such treatments and decid

巨碩

Salley Vickers, Venice, and the Victoriansparate disease characterised by hypersensitivity of the afferent vagus that investment in high-quality studies has been made. The finding that antagonism of the purinergic receptor P2X3 reduced cough counts has established chronic cough as a therapeutic opportunity. Gefapixant, the first in class P2

miscreant

options.This book is a practical resource for clinicians who manage patients with chronic cough, which represents a major challenge in the clinic due to multiple diagnostic and therapeutic considerations. Essential assessments for cough and treatable traits are described, covering the upper and low

嘮叨

Olfactory Ghosts: Michel Faber’s ance–pH monitoring as a gold standard for the detection of abnormal reflux. The favorable response to anti-reflux treatment is a key step to confirm reflux as the cause of chronic cough. In addition to lifestyle modification, pharmacological anti-reflux therapy is a first-line choice, and anti-reflux surgery is a promising option for cure.